Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,614 | 237 | 98.0% |
| Gift | $95.00 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,157 | 75 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $348.04 | 3 | $0 (2021) |
| PFIZER INC. | $327.38 | 15 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $269.25 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $228.12 | 14 | $0 (2024) |
| GENZYME CORPORATION | $204.68 | 4 | $0 (2024) |
| QOL Medical, LLC | $198.18 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $150.18 | 10 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $145.69 | 9 | $0 (2024) |
| Gilead Sciences, Inc. | $133.63 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $890.72 | 46 | ABBVIE INC. ($246.84) |
| 2023 | $1,065 | 43 | AbbVie Inc. ($223.43) |
| 2022 | $622.62 | 38 | ABBVIE INC. ($271.67) |
| 2021 | $414.60 | 19 | Janssen Scientific Affairs, LLC ($121.60) |
| 2019 | $508.89 | 21 | Janssen Scientific Affairs, LLC ($226.44) |
| 2018 | $623.87 | 31 | AbbVie, Inc. ($195.62) |
| 2017 | $584.02 | 41 | AbbVie, Inc. ($125.47) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/14/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $38.50 | General |
| Category: LIVER DISEASE | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/05/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.75 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $34.85 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: IMMUNOLOGY | ||||||
| 09/28/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/03/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Immunology | ||||||
| 08/28/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.20 | General |
| 08/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/16/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/13/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Rare Disease | ||||||
| 08/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 917 | 1,237 | $579,176 | $91,137 |
| 2022 | 13 | 939 | 1,377 | $622,083 | $88,757 |
| 2021 | 13 | 844 | 1,266 | $568,857 | $80,357 |
| 2020 | 19 | 911 | 1,259 | $549,245 | $73,716 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 119 | 120 | $114,097 | $21,682 | 19.0% |
| 46946 | Tying of multiple internal hemorrhoid groups | Facility | 2023 | 39 | 40 | $28,906 | $11,476 | 39.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 178 | 422 | $136,884 | $9,342 | 6.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 124 | 140 | $26,032 | $8,419 | 32.3% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 66 | 95 | $38,545 | $5,827 | 15.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 58 | 59 | $57,622 | $5,154 | 8.9% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 65 | 89 | $20,797 | $4,390 | 21.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 70 | 71 | $53,567 | $4,375 | 8.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 60 | 60 | $13,884 | $4,238 | 30.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 27 | 27 | $17,550 | $4,087 | 23.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 26 | 26 | $20,259 | $2,974 | 14.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 21 | 23 | $18,170 | $2,672 | 14.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 14 | 15 | $9,575 | $2,378 | 24.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $5,739 | $2,205 | 38.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 27 | 27 | $17,550 | $1,919 | 10.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 144 | 145 | $161,675 | $28,604 | 17.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 209 | 538 | $179,692 | $12,252 | 6.8% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 74 | 118 | $39,412 | $7,518 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 125 | $17,009 | $7,480 | 44.0% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 74 | 119 | $28,441 | $6,028 | 21.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 84 | 84 | $14,628 | $5,802 | 39.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 82 | 83 | $57,020 | $5,270 | 9.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 65 | 66 | $58,146 | $4,710 | 8.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 16 | 16 | $12,640 | $2,887 | 22.8% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 26 | 27 | $23,787 | $2,789 | 11.7% |
About Dr. John Tully, MD
Dr. John Tully, MD is a Gastroenterology healthcare provider based in Brooklyn, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1265619993.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Tully, MD has received a total of $4,709 in payments from pharmaceutical and medical device companies, with $890.72 received in 2024. These payments were reported across 239 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($4,614).
As a Medicare-enrolled provider, Tully has provided services to 3,611 Medicare beneficiaries, totaling 5,139 services with total Medicare billing of $333,966. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Brooklyn, OH
- Active Since 01/24/2008
- Last Updated 01/19/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1265619993
Products in Payments
- STELARA (Biological) $484.85
- RINVOQ (Biological) $396.41
- XELJANZ (Drug) $261.90
- Humira (Biological) $179.22
- ENTYVIO (Biological) $166.09
- VIBERZI (Drug) $164.11
- DIFICID (Drug) $162.95
- Mavyret (Drug) $153.58
- Sucraid (Drug) $137.20
- LINZESS (Drug) $135.07
- SKYRIZI (Biological) $126.98
- ZENPEP (Drug) $125.97
- XIFAXAN (Drug) $101.53
- ZEPOSIA (Drug) $98.50
- Cimzia (Drug) $93.18
- VIATORR Endoprosthesis (Device) $87.87
- DUPIXENT (Biological) $85.70
- OCALIVA (Drug) $82.01
- ORBERA Intragastric Balloon System (Device) $68.88
- HUMIRA (Biological) $66.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Brooklyn
Sam Moskowitz, Md, MD
Gastroenterology — Payments: $349,162
Jianjun Li, M.d, M.D
Gastroenterology — Payments: $307,830
Dr. Nison Badalov, M.d, M.D
Gastroenterology — Payments: $237,374
Smruti Mohanty, Md, Ms, MD, MS
Gastroenterology — Payments: $219,216
Dr. Jonathan Erber, Md, MD
Gastroenterology — Payments: $208,708
Dr. Rabin Rahmani, M.d, M.D
Gastroenterology — Payments: $204,380